Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer.

Ben-Chetrit N, Chetrit D, Russell R, Körner C, Mancini M, Abdul-Hai A, Itkin T, Carvalho S, Cohen-Dvashi H, Koestler WJ, Shukla K, Lindzen M, Kedmi M, Lauriola M, Shulman Z, Barr H, Seger D, Ferraro DA, Pareja F, Gil-Henn H, Lapidot T, Alon R, Milanezi F, Symons M, Ben-Hamo R, Efroni S, Schmitt F, Wiemann S, Caldas C, Ehrlich M, Yarden Y.

Sci Signal. 2015 Jan 20;8(360):ra7. doi: 10.1126/scisignal.2005537.

PMID:
25605973
2.
3.

Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.

Cohen H, Ben-Hamo R, Gidoni M, Yitzhaki I, Kozol R, Zilberberg A, Efroni S.

Breast Cancer Res. 2014 Nov 20;16(6):464. doi: 10.1186/s13058-014-0464-0.

4.

Heat acclimation memory: do the kinetics of the deacclimated transcriptome predispose to rapid reacclimation and cytoprotection?

Tetievsky A, Assayag M, Ben-Hamo R, Efroni S, Cohen G, Abbas A, Horowitz M.

J Appl Physiol (1985). 2014 Dec 1;117(11):1262-77. doi: 10.1152/japplphysiol.00422.2014. Epub 2014 Sep 18.

PMID:
25237184
5.

PhenoNet: identification of key networks associated with disease phenotype.

Ben-Hamo R, Gidoni M, Efroni S.

Bioinformatics. 2014 Sep 1;30(17):2399-405. doi: 10.1093/bioinformatics/btu199. Epub 2014 May 7.

PMID:
24812342
6.

SENP5 mediates breast cancer invasion via a TGFβRI SUMOylation cascade.

Cashman R, Cohen H, Ben-Hamo R, Zilberberg A, Efroni S.

Oncotarget. 2014 Feb 28;5(4):1071-82.

7.

Reprogrammed and transmissible intestinal microbiota confer diminished susceptibility to induced colitis in TMF-/- mice.

Bel S, Elkis Y, Elifantz H, Koren O, Ben-Hamo R, Lerer-Goldshtein T, Rahimi R, Ben Horin S, Nyska A, Shpungin S, Nir U.

Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4964-9. doi: 10.1073/pnas.1319114111. Epub 2014 Mar 17.

8.

MicroRNA-gene association as a prognostic biomarker in cancer exposes disease mechanisms.

Ben-Hamo R, Efroni S.

PLoS Comput Biol. 2013;9(11):e1003351. doi: 10.1371/journal.pcbi.1003351. Epub 2013 Nov 21.

9.

IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39.

Mascanfroni ID, Yeste A, Vieira SM, Burns EJ, Patel B, Sloma I, Wu Y, Mayo L, Ben-Hamo R, Efroni S, Kuchroo VK, Robson SC, Quintana FJ.

Nat Immunol. 2013 Oct;14(10):1054-63. doi: 10.1038/ni.2695. Epub 2013 Sep 1.

10.

Altered immune pathway activity under exercise challenge in Gulf War Illness: an exploratory analysis.

Broderick G, Ben-Hamo R, Vashishtha S, Efroni S, Nathanson L, Barnes Z, Fletcher MA, Klimas N.

Brain Behav Immun. 2013 Feb;28:159-69. doi: 10.1016/j.bbi.2012.11.007. Epub 2012 Nov 29.

PMID:
23201588
12.

RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferation.

Feldstein O, Ben-Hamo R, Bashari D, Efroni S, Ginsberg D.

Mol Cancer Res. 2012 Sep;10(9):1169-77. Epub 2012 Jul 13.

13.
15.

Rep-Seq: uncovering the immunological repertoire through next-generation sequencing.

Benichou J, Ben-Hamo R, Louzoun Y, Efroni S.

Immunology. 2012 Mar;135(3):183-91. doi: 10.1111/j.1365-2567.2011.03527.x. Review.

16.

The whole-organism heavy chain B cell repertoire from Zebrafish self-organizes into distinct network features.

Ben-Hamo R, Efroni S.

BMC Syst Biol. 2011 Feb 10;5:27. doi: 10.1186/1752-0509-5-27.

17.

Detecting cancer gene networks characterized by recurrent genomic alterations in a population.

Efroni S, Ben-Hamo R, Edmonson M, Greenblum S, Schaefer CF, Buetow KH.

PLoS One. 2011 Jan 4;6(1):e14437. doi: 10.1371/journal.pone.0014437.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk